Single-Use
The Changing Economics of Single-Use Biomanufacturing
Pharma's Almanac
PAO-09-26-PA-08Sep 10, 2026
CDMO Governance
The Governance Gap: Why Good CDMO Partnerships Still Fail
Pharma's Almanac
PAO-09-26-PA-07Sep 9, 2026
Pathfinder
Conventional Peptide Synthesis vs. Recombinant Peptide Production: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-23Sep 4, 2026
Productivity
The Next Productivity Leap in Mammalian Cell Culture
Pharma's Almanac
PAO-09-26-PA-03Sep 3, 2026
Development CDMO
The Case for Earlier CDMO Involvement in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-02Sep 2, 2026
Capacity
Is the Bioreactor Arms Race Over?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-01Sep 1, 2026
Chinese Biopharma
Pharmaceutical Innovation in China Takes Center Stage
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-17Aug 25, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16Aug 24, 2026
Supply Chain
Supply Chain Resilience in 2026: Any Progress?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-15Aug 19, 2026
Asia Manufacturing
The New Manufacturing Map of Asia
Pharma's Almanac
PAO-08-26-PA-03Aug 5, 2026
Asia Manufacturing
APAC Expands Specialized Manufacturing Capabilities Across High-Value Modalities
Pharma's Almanac
PAO-08-26-PA-02Aug 3, 2026
Combination Products
Collaboration is Key to Successful Injectable Drug–Device Combination Product Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-05Jul 27, 2026
LAI Formulation
The Formulation Science Behind Extended Drug Release
Pharma's Almanac
PAO-07-26-PA-03Jul 9, 2026
Tech Transfer
Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success
Pharma's Almanac
PAO-06-26-PA-22Jun 25, 2026
U.S. CDMO Capacity
More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand
Pharma's Almanac
PAO-06-26-PA-18Jun 22, 2026
Supply Chain
Outsourcing, Fragmentation, and the New Supply Chain Resilience Challenge
Pharma's Almanac
PAO-06-26-PA-07Jun 12, 2026
Outsourcing
The Hidden Operational Costs of Multi-Vendor Outsourcing Models
Pharma's Almanac
PAO-06-26-PA-06Jun 11, 2026
Peptides
Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-26-PA-13Jun 9, 2026
Psychedelics CMC
The CMC Challenge for Psychedelic Drugs
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-21May 22, 2026
Peptide Production
Peptide Manufacturing Enters the Industrial Era
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-17May 18, 2026